Table 1.
Men | Women | |||||
---|---|---|---|---|---|---|
Healthy | Ow/Ob | T2D | Healthy | Ow/Ob | T2D | |
n | 29 | 11 | 31 | 22 | 20 | 21 |
Age (y) | 53 ± 20 | 45 ± 18 | 54 ± 6 | 47 ± 24 | 56 ± 19 | 61 ± 10 |
BMI (kg/m2)a,b,c | 23.3 ± 2.3d | 32.2 ± 3.1e | 31.2 ± 4.0e | 22.3 ± 2.4d | 34.2 ± 4.8e | 34.4 ± 5.4e |
Waist (cm)a,b,c | 86 ± 8d | 109 ± 7e | 111 ± 12e | 74 ± 9d | 102 ± 12e | 110 ± 11e |
Waist/hip ratioa,b | 0.91 ± 0.06d | 0.99 ± 0.04e | 1.02 ± 0.06e | 0.78 ± 0.07d | 0.86 ± 0.08e | 0.94 ± 0.09f |
Body fat (%)a,b,c | 21.3 ± 7.7d | 33.7 ± 4.7e | 30.2 ± 4.8e | 30.9 ± 7.6d | 47.5 ± 4.8e | 46.8 ± 5.4e |
FFM (kg)a,b | 56.1 ± 6.0d | 66.5 ± 5.5e | 67.0 ± 8.9e | 39.1 ± 3.5d | 46.0 ± 6.6e | 47.2 ± 6.2e |
FFM index (kg/m2)g,h | 18.3 ± 1.1i | 21.3 ± 1.6j | 21.6 ± 1.9j | 15.3 ± 1.1i | 17.8 ± 1.7j | 18.1 ± 2.0j |
REE (kcal/d)a,b | 1552 ± 181d | 1916 ± 237e | 1832 ± 194e | 1270 ± 129d | 1506 ± 235e | 1580 ± 265e |
RQa,b,c | 0.78 ± 0.05 | 0.83 ± 0.06 | 0.78 ± 0.05 | 0.80 ± 0.04d | 0.77 ± 0.04d,e | 0.76 ± 0.03e |
FFAs (µmol/L)a | 501 ± 186 | 491 ± 67 | 480 ± 154 | 744 ± 194 | 681 ± 174 | 798 ± 228 |
HOMA-IRh | 2.18 ± 0.64i | 2.78 ± 1.02i | 7.01 ± 2.45j | 1.98 ± 0.48i | 3.70 ± 1.48j | 7.11 ± 3.45k |
Fasting insulin (pmol/L)h | 58 ± 15i | 72 ± 27i | 120 ± 40j | 53 ± 13i | 95 ± 36j | 126 ± 59j |
Fasting glucose (mmol/L)h | 5.4 ± 0.4i | 5.3 ± 0.3i | 8.6 ± 2.1j | 5.1 ± 0.3i | 5.4 ± 0.4j | 8.6 ± 2.3k |
Fasting glucagon (pmol/L)g | 20 ± 7i | 28 ± 11j | 25 ± 10j | 21 ± 7 | 20 ± 5 | 18 ± 5 |
Clamp IR indexes | ||||||
Glucose Rd (mg/kg FFM/min)b | 8.7 ± 2.4d | 6.1 ± 1.4e | 4.0 ± 0.9f | 9.1 ± 1.8d | 6.5 ± 1.6e | 4.9 ± 1.0f |
M/I indexb | 12.5 ± 5.3d | 6.7 ± 3.1e | 1.8 ± 1.9f | 12.6 ± 4.0d | 6.1 ± 2.3e | 2.8 ± 3.0f |
Hepatic IR indexa,b | −4.6 ± 1.5d | −3.7 ± 1.2d,e | −3.5 ± 1.3e | −5.6 ± 1.4d | −4.3 ± 1.4e | −4.2 ± 1.7e |
Data are means ± SD.
Abbreviation: REE, resting energy expenditure.
M/I index = Δ glucose Rd (mg/kg FFM/min)/clamp plasma insulin (pmol/L) × 1000.
Hepatic IR index = Δ glucose Ra (mg/kg FFM/min)/clamp plasma insulin (pmol/L) × 1000.
Analysis by two-factor ANOVA:
Sex effect.
Group effect.
Sex-by-group interaction, P < 0.05.
Within each sex, groups with different superscripts differ by post hoc Bonferroni test, P < 0.05.
Sex effect by Mann–Whitney U test, P < 0.05.
Group effect by Kruskal–Wallis test in both sexes.
Within each sex, groups with different superscripts differ by post hoc Mann–Whitney U test, P < 0.05.